PedAM

Pediatric Disease Annotations & Medicines

Disease	cystic fibrosis
Symptom	C0024115\|pulmonary disease
Sentences	16
PubMedID- 21382698	Aeruginosa isolated from intubated patients and from patients with chronic pulmonary disease associated with cystic fibrosis (cf).
PubMedID- 23614789	Receptor-targeted nanocomplexes are nonviral vectors developed for gene delivery to the airway epithelium for the treatment of pulmonary disease associated with cystic fibrosis.
PubMedID- 20592996	The most frequent underlying disorders are chronic obstructive pulmonary disease with emphysema, cystic fibrosis, tuberculosis, lung cancer, or hiv-associated pneumocystis jiroveci pneumonia, as well as more rare disorders such as lymphangioleiomyomatosis or langerhans cell histiocytosis .
PubMedID- 24568560	Rationale: smoking-induced chronic obstructive pulmonary disease (copd) is associated with acquired systemic cystic fibrosis transmembrane conductance regulator (cftr) dysfunction.
PubMedID- 25592857	M. europaeum was isolated from the sputum samples of an iranian human immunodeficiency virus-infected patient and a cystic fibrosis patient with chronic pulmonary disease while m. nonchromogenicum has been associated with sarcoidosis .
PubMedID- 26047320	Chronic airway infections caused by pseudomonas aeruginosa contribute to the progression of pulmonary disease in individuals with cystic fibrosis (cf).
PubMedID- 25405888	Allergic bronchopulmonary aspergillosis is a pulmonary disease occurring in patients with asthma or cystic fibrosis, consequent to a dysregulated immune response to inhaled aspergillus conidia.
PubMedID- 23852992	Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis.
PubMedID- 25392361	The evolution of pulmonary disease in cystic fibrosis (cf) usually begins when bacteria get trapped in mucus in the lungs and become established as a chronic infection.
PubMedID- 20093379	The 'streptococcus milleri' group (smg) has recently been recognized as a contributor to bronchopulmonary disease in cystic fibrosis (cf).
PubMedID- 21124947	Finally, recombinant human dnase i has been developed clinically for treatment of pulmonary disease in patients with cystic fibrosis , .
PubMedID- 25057981	pulmonary disease in cystic fibrosis: assessment with chest ct at chest radiography dose levels.
PubMedID- 22184909	Strains usually are capable to secret a capsule-like polysaccharide called alginate important for evasion of host defenses, especially during chronic pulmonary disease of patients with cystic fibrosis.
PubMedID- 24818948	Bacteria enmeshed in agar beads can be used in the rat and mouse to reproduce the lung pathology of cystic fibrosis patients with advanced chronic pulmonary disease.
PubMedID- 23677424	The studies support the notion that aortopulmonary collateral blood flow may serve as a novel and sensitive biomarker of early pulmonary disease in cystic fibrosis.
PubMedID- 20398325	Such polymicrobial infections occur in the lungs of cystic fibrosis patients, in patients with chronic obstructive pulmonary disease, as well as at sites in immunocompromized patients.

Page: 1